Price T Rowe Associates Inc Co Diagnostics, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $287,448 - $367,098	-35,400 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $31,416 - $47,796	-4,200 Reduced 10.61%	35,400 $344,000
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $56,771 - $75,801	-7,929 Reduced 16.68%	39,600 $327,000
Q1 2021 May 17, 2021	SELL	$8.52 - $19.21 $42,080 - $94,878	-4,939 Reduced 9.41%	47,529 $453,000
Q4 2020 Feb 16, 2021	BUY	$9.3 - $15.19 $487,952 - $796,988	52,468 New	52,468 $488,000

5.59M

67.5K

174K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $15.9M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.